Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Interim Financial Statements to 31 December 2025

17th Mar 2026 16:00

RNS Number : 0091X
MAC Alpha Limited
17 March 2026
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

 

LEI number: 254900LOBYWJWYSAB947

17 March 2026

 

MAC Alpha Limited

(the "Company")

 

Interim Financial Statements for the period ended 31 December 2025

 

The Company announces the publication of its Interim Financial Statements for the period ended 31 December 2025.

The Interim Financial Statements are also available on the 'Shareholder Documents' page of the Company's website at www.mac-alpha.com.

Enquiries:

Company Secretary

Antoinette Vanderpuije - 020 7004 2700

 

MAC ALPHA LIMITED

Unaudited Interim

Condensed Consolidated Financial Statements for the six months ended 31 December 2025

 

MANAGEMENT REPORT

We present to shareholders the unaudited condensed consolidated financial statements of MAC Alpha Limited (the "Company") for the six months to 31 December 2025 (the "Interim Financial Statements"), consolidating the results of MAC Alpha Limited and its subsidiary, MAC Alpha (BVI) Limited (the "Subsidiary") (collectively, the "Group").

Strategy and Activity

The Company was incorporated on 11 October 2021 and subsequently listed on the Main Market of the London Stock Exchange on 24 December 2021. The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation, or similar business combination with one or more businesses.

The Company's objective is to generate attractive long term returns for shareholders and to enhance value by supporting sustainable growth, acquisitions, and performance improvements within the acquired companies.

On 6 October 2025, the Company announced the appointment of Avril Palmer-Baunack as Chairman. Avril brings a wealth of experience in the automotive, support services, engineering and insurance sectors. Accordingly, the Company continues to consider platform acquisition opportunities across a variety of sectors (Automotive & Transport, Business-to-Business Services, Clean Technology, Consumer & Luxury Goods, Financial Services, Banking & FinTech, Insurance, Reinsurance & InsurTech, & Other Vertical Marketplaces, Healthcare & Diagnostics and Media & Technology) where they believe that a combination of management expertise, improving operating performance, freeing up cashflow for investment and implementation of a focussed buy and build strategy can unlock growth in their core markets and often into new territories and adjacent sectors to ultimately deliver shareholder value.

Results

The Group's loss after taxation for the period to 31 December 2025 was £197,823 (31 December 2024: loss of £152,099). The Group held a cash balance at the period end of £265,120 (as at 30 June 2025: £464,322). The Group has not yet acquired an operating business and as such is not yet revenue generating.

Directors

The Directors of the Company have served as directors during the period and until the date of this report as set out below:

Avril Palmer-Baunack (Chairman) (appointed 6 October 2025);

James Corsellis (Director);

Antoinette Vanderpuije (Non-Executive Director); and

Tom Basset (Non-Executive Director).

Dividend Policy

The Company has not yet acquired a trading business and it is therefore inappropriate to make a forecast of the likelihood of any future dividends. The Directors intend to determine the Company's dividend policy following completion of a platform acquisition (an "Initial Acquisition") and, in any event, will only commence the payment of dividends when it becomes commercially prudent to do so.

Corporate Governance

Under the UK Listing Rules, the Company is included in the Shell Companies Category and therefore is not required to comply with the provisions of the UK Corporate Governance Code.

Given the size and nature of the Group the Directors have decided not to voluntarily adopt the UK Corporate Governance Code at this time. Nevertheless, the Board is committed to maintaining high standards of corporate governance and will consider whether to voluntarily adopt and comply with the UK Corporate Governance Code in conjunction with an Initial Acquisition, taking into account the Company's size and status at that time.

The Company currently complies with the following principles of the UK Corporate Governance Code:

· The Company is led by an effective and entrepreneurial Board of Directors (the "Board''), whose role is to promote the long term sustainable success of the Company, generating value for shareholders and contributing to wider society;

· The Board ensures that it has the policies, processes, information, time and resources it needs in order to function effectively and efficiently; and

· The Board ensures that the necessary resources are in place for the Company to meet its objectives and measure performance against them.

Given the size and nature of the Company, the Board has not established any committees and intends to make decisions as a whole. If the need should arise in the future, for example following an Initial Acquisition, the Board may set up committees and may decide to comply with the UK Corporate Governance Code.

Risks

The Directors have carried out a robust assessment of the principal risks facing the Group including those that would threaten its business model, future performance, solvency or liquidity. There have been no significant changes to the principal risks described in the Group's Audited Annual Report and Consolidated Financial Statements for the year ended 30 June 2025, which are available on the Company's website. The Directors are of the opinion that the risks detailed therein are applicable to the six-month period to 31 December 2025, as well as the remaining six months of the current financial year.

Outlook

The Directors remain highly confident that the listed status and flexible structure of the Company will provide an attractive platform from which to execute its buy-and-build growth strategy.

RESPONSIBILITY STATEMENT

Each of the Directors confirms that, to the best of their knowledge:

(a) these Interim Financial Statements, which have been prepared in accordance with IAS 34 "Interim Financial Reporting" as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Company; and

(b) these Interim Financial Statements comply with the requirements of DTR 4.2.

Neither the Company nor the Directors accept any liability to any person in relation to the interim financial report except to the extent that such liability could arise under applicable law.

Details on the Company's Board of Directors can be found on the Company website at www.mac-alpha.com.

 

 

Avril Palmer-Baunack Chairman17 March 2026

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

 

Six months ended

 

Six months ended

 

 

31 December

 

31 December

 

 

2025

 

2024

 

Note

Unaudited

 

Unaudited

 

 

£'s

 

£'s

 

 

 

Administrative expenses

6

(204,460)

(156,243)

Total operating loss

 

(204,460)

 

(156,243)

Finance income

6,637

4,144

Loss before income taxes

(197,823)

 

(152,099)

Income tax

-

-

Loss for the period

 

(197,823)

 

(152,099)

Total other comprehensive income

 

-

-

Total comprehensive loss for the period

 

(197,823)

 

(152,099)

 

Loss per ordinary share

 

£'s

 

£'s

Basic and Diluted

7

(0.1099)

(0.1170)

 

The Group's activities derive from continuing operations.

The Notes on pages 9 to 20 form an integral part of these Interim Financial Statements.

CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

As at

31 December 2025

 

As at

30 June

2025

Note

Unaudited

 

Audited

 

£'s

 

£'s

Assets

 

 

 

 

Current assets

 

 

 

 

Other receivables

9

12,609

 

5,500

Cash and cash equivalents

10

265,120

 

464,322

Total current assets

277,729

 

469,822

 

 

Total assets

277,729

 

469,822

 

 

Equity and liabilities

 

 

Equity

 

 

Ordinary Shares

12

319,000

 

319,000

A Shares

12

938,000

 

938,000

Sponsor Share

12

1

 

1

Warrant reserve

12, 13

105,000

 

105,000

A Warrant reserve

12, 13

162,000

 

162,000

Share-based payment reserve

13, 15

71,851

 

67,516

Accumulated losses

13

(1,407,400)

 

(1,209,577)

Total equity

188,452

 

381,940

 

 

 

Current liabilities

 

 

Trade and other payables

11

89,277

 

87,882

Total liabilities

 

89,277

 

87,882

 

 

 

Total equity and liabilities

 

277,729

 

469,822

 

The Notes on pages 9 to 20 form an integral part of these Interim Financial Statements.

The Interim Financial Statements were approved by the Board of Directors on 17 March 2026 and were signed on its behalf by:

 

 

 

Avril Palmer-Baunack

Chairman

Tom Basset

Non-Executive Director

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

Ordinary

shares

A

Shares

Sponsor

Share

Warrant

reserve

Warrant

reserve

A Shares

Share

Based

Payment

Reserve

Accumulated

losses

Total

equity

£'s

£'s

£'s

£'s

£'s

£'s

£'s

£'s

Balance at 1 July 2024

319,000

498,000

1

105,000

102,000

67,516

(875,034)

216,483

Total comprehensive loss for the period

-

-

-

-

-

-

(152,099)

(152,099)

Balance as at 31 December 2024

319,000

498,000

1

105,000

102,000

67,516

(1,027,133)

64,384

 

 

 

 

 

 

 

 

 

Ordinary

shares

A

Shares

Sponsor

Share

Warrant

reserve

Warrant

reserve

A Shares

Share

Based

Payment

Reserve

Accumulated

losses

Total

Equity

 

£'s

£'s

£'s

£'s

£'s

£'s

£'s

£'s

Balance at 1 July 2025

319,000

938,000

1

105,000

162,000

67,516

(1,209,577)

381,940

Share based payment charge (Note 15)

-

-

-

-

-

4,335

-

4,335

Total comprehensive loss for the period

-

-

-

-

-

-

(197,823)

(197,823)

Balance as at 31 December 2025

319,000

938,000

1

105,000

162,000

71,851

(1,407,400)

188,452

 

The Notes on pages 9 to 20 form an integral part of these Interim Financial Statements.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

Six months ended

31 December

2025

 

Six months ended

31 December

2024

Note

Unaudited

 

Unaudited

 

£'s

 

£'s

Operating activities

Loss for the period

(197,823)

(152,099)

Adjustments to reconcile total operating loss to net cash flows:

Deduct finance income

(6,637)

(4,144)

Add back share-based payment expense

15

4,335

-

Working capital adjustments:

Increase in trade and other receivables and prepayments

9

(7,109)

(6,989)

Decrease in trade and other payables

11

(27,943)

(19,413)

Net cash flows used in operating activities

(235,177)

 

(182,645)

Investing activities

Interest received

6,637

4,144

Net cash flows received from investing activities

6,637

4,144

Financing activities

Proceeds from issue of Incentive Shares

15

29,338

-

Net cash flows from financing activities

29,338

-

Net decrease in cash and cash equivalents

(199,202)

(178,501)

Cash and cash equivalents at the beginning of the period

464,322

270,534

Cash and cash equivalents at the end of the period

10

265,120

 

92,033

 

The Notes on pages 9 to 20 form an integral part of these Interim Financial Statements.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. GENERAL INFORMATION

MAC Alpha Limited was incorporated on 11 October 2021 in the British Virgin Islands ("BVI") as a BVI business Company (registered number 2078235) under the BVI Business Company Act, 2004. The Company was listed on the London Stock Exchange on 24 December 2021 and has its registered address at Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, VG1110, British Virgin Islands and a UK establishment (BR028157) at 11 Buckingham Street, London, WC2N 6DF.

The Company has been formed for the purpose of effecting a merger, share exchange, asset acquisition, share or debt purchase, reorganisation, or similar business combination with one or more businesses. The Company has one subsidiary, MAC Alpha (BVI) Limited (together with the Company, the Group).

The transitional provisions of the UK Listing Rules ("UKLRs") expired on 29 July 2025 (which have applied to the Company as a shell company since 29 July 2024 (the "Transition Period")). The Company announced on 28 July 2025 that it had adopted a revised memorandum and articles of association of the Company (the "New Constitution") in accordance with this.

The New Constitution was prepared in accordance with the requirements of UKLR13.2.1, which applied to the Company following the expiry of the Transition Period. UKLR13.2.1 primarily requires that the Company's constitution includes a requirement that it will cease operations if it has not completed an Initial Transaction (as defined in UKLR13) within a 24-month period from 30 July 2025 (the "Initial Transaction Deadline"). The New Constitution also provides that (as permitted by the UKLRs) the Initial Transaction Deadline may be extended by shareholder approval for up to three further 12-month periods (plus a further six months in certain circumstances if an incomplete Initial Transaction is in progress).

The Company therefore currently expects that, if an Initial Transaction has not been completed on or before July 2027, an initial shareholder vote will be proposed on or before July 2027 in order to seek an extension to the Initial Transaction Deadline.

2. ACCOUNTING POLICIES

(a) Basis of preparation

These Interim Financial Statements have been prepared in accordance with IAS 34 Interim Financial Reporting and are presented on a condensed basis.

The Interim Financial Statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Group's Annual Report and Audited Consolidated Financial Statements for the year ended 30 June 2025 ("2025 Annual Report"), which is available on the Company's website, www.mac-alpha.com. Accounting policies applicable to these Interim Financial Statements are consistent with those applied in the 2025 Annual Report.

(b) Going concern

The Interim Financial Statements have been prepared on a going concern basis, which assumes that the Group will continue to be able to meet its liabilities as they fall due the foreseeable future. The Group had cash resources of £265,120 at 31 December 2025 (30 June 2025: £464,322) and net assets of £188,452 (30 June 2025: £381,940). The Directors have considered the financial position of the Group and reviewed forecasts and budgets for a period of at least 12 months following the approval of the Interim Financial Statements.  

On 16 December 2021, the Company entered into a forward purchase agreement ("FPA") with Marwyn Value Investors II LP (''MVI II LP'') of up to £20 million, which may be drawn for general working capital purposes and to fund due diligence costs. Any drawdown is subject to the prior approval of MVI II LP, who has assigned discretionary authority for portfolio and risk management to Marwyn Investment Management LLP (''MIM LLP'') under the terms of a management agreement, and the satisfaction of conditions precedent. On 5 March 2023, the Company drew down £600,000 under the FPA and accordingly issued 600,000 A shares ("A Shares") and 600,000 matching A warrants ("A Warrants") as set out in the FPA.

On 14 February 2025, the Company drew down a further £500,000 under the FPA and accordingly issued 500,000 A Shares and 500,000 matching A Warrants. As at the date of these accounts, MIM LLP as manager of the Marwyn Funds has provided a letter of support ("Letter of Support") which states that its current intention is to provide the financial resources needed to support the Group in continuing to pursue its stated strategy. It is expected that any necessary financing will be provided via the FPA.

The Directors have reviewed the working capital model for the Group in detail and considered the Letter of Support and are therefore satisfied that the Company will have sufficient cash to meet its ongoing operating costs for a period of at least 12 months from the approval of the Interim Financial Statements and have sufficient resources to continue to pursue its stated strategy.

(c) New standards and amendments to International Financial Reporting Standards

Standards, amendments and interpretations effective and adopted by the Group

The International Financial Reporting Standards ("IFRS") applicable to the Interim Financial Statements of the Group for the six-month period to 31 December 2025 have been applied.

Standards issued but not yet effective

The following standards are issued but not yet effective. The Group intends to adopt these standards, if applicable, when they become effective. It is not currently expected that these standards will have a material impact on the Group. The Company notes that whilst the revisions set out in IFRS 18 are not assessed as impacting the reported results or financial position of the Company, the layout and line items within the primary statements may vary when the IFRS becomes effective. This is a presentation matter only and does not affect recognition or measurement.

Standard

Effective date

Amendments IFRS 9 and IFRS 7 regarding the classification and measurement of financial instruments*

1 January 2026

IFRS 18 - Presentation and Disclosure of financial Statements*

1 January 2027

IFRS 19 - Subsidiaries without Public Accountability: Disclosures

1 January 2027

*Subject to EU endorsement

3. CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

The preparation of the Group's Interim Financial Statements under IFRS requires the Directors to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities. Estimates and judgements are continually evaluated and are based on historical experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. Actual results may differ from these estimates.

Critical accounting judgements

Classification of Warrants

On 24 December 2021, the Company issued 700,000 ordinary shares ("Ordinary Shares") and matching warrants ("Warrants"). Under the terms of the warrant instrument, warrant holders are able to acquire one Ordinary Share per Warrant at a price of £1 per Ordinary Share. The Warrants are exercisable at any time until five years after the IPO date, being 24 December 2021 (the "IPO Date"). Further on 5 March 2023, the Company issued 600,000 A Shares and matching Class A Warrants being issued on the basis of one Class A Warrant per A Share at a price of £1 per share. The A Warrants are exercisable at any time until five years after the IPO Date. On 14 February 2025, the Company issued a further 500,000 A Shares and matching A Warrants on the same terms as the 5 March 2023 issue.

The Warrants and A Warrants can only be classified as equity if they will be settled only by the issuer exchanging a fixed amount of cash or another financial asset for a fixed number of its own equity instruments.

The warrant instruments contain an exercise price adjustment ("Exercise Price Adjustment"), whereby if the corresponding shares are issued at less than £1 before or as part of an acquisition then the exercise price equals the discounted issue price, as a result, the fixed-for-fixed requirement is breached. However, it is the opinion of the Directors that whilst the Exercise Price Adjustment exists, the likelihood of this being used is remote, and therefore it is most appropriate for the Warrants and A Warrants to be classified as equity.

Critical accounting estimates

Valuation of Incentive Scheme

The Company has issued incentive shares ("Incentive Shares") in the period as detailed in Note 15. There are significant estimates and assumptions used in the valuation of the Incentive Shares in issue. Management has considered at the grant date, being the date that such shares are issued (the "Grant Date"), the probability of a successful Initial Acquisition by the Group and the potential range of values for the Incentive Shares, based on the circumstances on the Grant Date. The fair value of the Incentive Shares and related share-based payment expense was calculated using a Monte Carlo valuation model.

Other disclosures relating to the Group's exposure to risk and uncertainties in relation to financial instruments are included in Note 14.

4. SEGMENT INFORMATION

The Board of Directors is the Group's chief operating decision-maker. As the Group has not yet acquired an operating business, the Board considers the Group as a whole for the purposes of assessing performance and allocating resources, and therefore the Group has one reportable operating segment.

5. EMPLOYEES AND DIRECTORS

The Group does not have any employees. During the six months to 31 December 2025, the Company had four serving Directors as detailed on page 3, no Director received remuneration under the terms of their Director service agreements during the period ending 31 December 2025 (31 December 2024: 3 Directors and £Nil). The Subsidiary has issued Incentive Shares, as more fully disclosed in Note 15, in which Avril Palmer-Baunack is directly beneficially interested and the other Directors are indirectly beneficially interested.

6. ADMINISTRATIVE EXPENSES

 

Six months ended

31 December

2025

 

Six months ended

31 December

2024

 

Unaudited

 

Unaudited

 

£'s

 

£'s

Group expenses by nature

 

 

 

Professional support

188,486

145,590

Audit fees payable in respect of the audit of the Group

10,104

9,070

Other expenses

5,870

1,583

204,460

 

156,243

7. LOSS PER ORDINARY SHARE

Basic EPS is calculated by dividing the loss attributable to equity holders of the company by the weighted average number of Ordinary Shares in issue during the period. Diluted EPS is calculated by adjusting the weighted average number of Ordinary Shares outstanding to assume conversion of all dilutive potential Ordinary Shares. The weighted average number of shares has not been adjusted in calculating diluted EPS as there are no instruments which have a current dilutive effect.

The Company maintains different share classes, of which Ordinary Shares, A Shares and Sponsor Shares were in issue in the current and prior period. The key difference between Ordinary Shares and A Shares is that the Ordinary Shares are traded with voting rights attached and that the A Shares are not listed and do not carry voting rights. The Ordinary Share and A Share classes both have equal rights to the residual net assets of the Company, which enables them to be considered collectively as one class per the provisions of IAS 33.

The Sponsor Share has no distribution rights so has been ignored for the purposes of IAS 33. Further detail on the Sponsor Share has been included in Note 12.

Refer to Note 15 (share-based payments) for instruments that could potentially dilute basic EPS in the future.

 

 

Six months ended

31 December

2025

 

Six months ended

31 December

2024

 

Unaudited

 

Unaudited

£'s

 

£'s

Loss attributable to owners of the parent (£'s)

(197,823)

 

(152,099)

Weighted average in issue

1,800,000

1,300,000

Basic and diluted loss per Ordinary Share (£'s)

(0.1099)

(0.1170)

8. INVESTMENTS

Principal subsidiary undertakings of the Group

The Company directly owns the whole of the issued ordinary share capital of its Subsidiary. Details of the Company's Subsidiary are presented below:

 

Subsidiary

Nature of business

Country of incorporation

Proportion of ordinary shares held by parent

Proportion of ordinary shares held by the Group

MAC Alpha (BVI) Limited

Incentive vehicle

BVI

100%

100%

The share capital of the Subsidiary consists of both ordinary shares and Incentive Shares. The Incentive Shares, are non-voting, are held by Marwyn Long Term Incentive LP (''MLTI'') and Avril Palmer-Baunack. Further detail on the Incentive Shares is given in Note 15.

The registered office of the Subsidiary is Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola, British Virgin Islands VG1110, British Virgin Islands and its UK establishment address is 11 Buckingham Street, London, WC2N 6DF.

9. OTHER RECEIVABLES

 

As at

31 December

2025

 

As at

30 June

 2025

 

Unaudited

 

Audited

 

£'s

 

£'s

 Amounts receivable in one year:

 

 

 

 Prepayments

12,609

5,500

12,609

 

5,500

There is no material difference between the book value and the fair value of the receivables. Receivables are considered to be past due once they have passed their contracted due date. Other receivables are all current.

10. CASH AND CASH EQUIVALENTS

 

As at

31 December

2025

 

As at

30 June

2025

 

Unaudited

 

Audited

 

£'s

 

£'s

Cash and cash equivalents

 

 

 

Cash at bank

265,120

464,322

265,120

 

464,322

Credit risk is managed on a Group basis. Credit risk arises from cash and cash equivalents and deposits with banks and financial institutions. For banks and financial institutions, only independently rated parties with a minimum short-term credit rating of P-1, as issued by Moody's, are accepted.

11. TRADE AND OTHER PAYABLES

 

As at

31 December

2025

 

As at

30 June

2025

 

Unaudited

 

Audited

 

£'s

 

£'s

 Amounts falling due within one year:

 Trade payables

3,010

11,941

 Accruals

35,389

42,094

 Due to a related party (Note 16)

21,540

33,847

 Incentive Share liability (Note 15)

29,338

-

89,277

 

87,882

There is no material difference between the book value and the fair value of the trade and other payables. All trade payables are non-interest bearing and are usually paid within 30 days.

12. STATED CAPITAL

 

Authorised

Unlimited Ordinary Shares of no par value

Unlimited A Shares of no par value

Unlimited B shares of no par value

100 Sponsor Shares of no par value

 

 

As at

31 December

2025

 

As at

30 June

2025

 

Unaudited

 

Audited

 

£'s

 

£'s

Issued

 

 

 

700,000 Ordinary Shares of no par value

319,000

319,000

1,100,000 A Shares of no par value

938,000

938,000

1 Sponsor Share of no par value

1

1

On incorporation, the Company issued 1 Ordinary Share of no par value to MVI II LP. On 28 October 2021, it was resolved that updated memorandum and articles of association (the "Updated M&A") be adopted by the Company and with effect from the time the Updated M&A be registered with the Registrar of Corporate Affairs in the British Virgin Islands, the 1 Ordinary Share which was in issue by the Company be redesignated as 1 sponsor share of no par value (the "Sponsor Share").

On 24 December 2021, the Company issued 700,000 Ordinary Shares and matching Warrants at a price of £1 for one Ordinary Share and matching Warrant. Under the terms of the Warrant instrument, Warrant holders are able to acquire one Ordinary Share per Warrant at a price of £1 per Ordinary Share. Warrants are accounted for as equity instruments under IAS 32 and are measured at fair value at Grant Date, the combined market value of one Ordinary Share and one Warrant was considered to be £1, in line with the market price paid by third party investors. A Black-Scholes option pricing methodology was used to determine the fair value of the Warrants, which considered the exercise price, expected volatility, risk free rate, expected dividends and expected term. Warrants have been assigned a fair value of 15p per Warrant and each Ordinary Share has been valued at 85p per share, therefore, on issuance of the Warrants £105,000 was recorded in the Warrant reserve. Costs of £276,000 directly attributable to the equity raise were taken against stated capital at the issuance date.

A Warrants are accounted for as equity instruments under IAS 32 and are measured at fair value at Grant Date. For both the issuance on 5 March 2023 and the issuance on 14 February 2025, the A Shares and matching A Warrants were issued at a price of £1 for one A share and matching A Warrant. Under the terms of the A Warrant instrument, A Warrant holders are able to acquire one Ordinary Share per A Warrant at a price of £1 per A share. A Black-Scholes option pricing methodology was used to determine the fair value of the A Warrants at their respective Grant Dates, which considered the exercise price, expected volatility, risk free rate, expected dividends and expected term.

For the 600,000 A Shares and matching A Warrants issued by the Company on 5 March 2023, A Warrants have been assigned a fair value of 17p per A Warrant and each A share has been valued at 83p per share, therefore, on issuance of the A Warrants £102,000 was recorded in the Warrant reserve. There were no costs directly attributable to the issue of shares.

For the 500,000 A Shares and matching A Warrants issued by the Company on 14 February 2025, A Warrants have been assigned a fair value of 12p per A Warrant and each A Share has been valued at 88p per share, therefore, on issuance of the A Warrants £60,000 was recorded in the A Warrant reserve. There were no costs directly attributable to the issue of shares.

Holders of Ordinary Shares are entitled to receive notice and attend and vote at any meeting of members and have the right to a share in any distribution paid by the Company and a right to a share in the distribution of the surplus assets of the Company on a winding up. The A Shares are ordinary equity shares with the same economic rights as the Company's Ordinary Shares but without voting rights.

The Sponsor Share confers upon the holder no right to receive notice and attend and vote at any meeting of members, no right to any distribution paid by the Company and no right to a share in the distribution of the surplus assets of the Company on a winding up. Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares), they have the right to appoint one director to the Board.

Provided the holder of the Sponsor Share holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares) or is a holder of Incentive Shares the Company must receive the prior consent of the holder of the Sponsor Share in order to:

i. issue any further Sponsor Shares;

ii. issue any class of shares on a non pre-emptive basis where the Company would be required to issue such share pre-emptively if it were incorporated under the UK Companies Act 2006 and acting in accordance with the Pre-Emption Group's Statement of Principles;

iii. amend, alter, or repeal any existing, or introduce any new share-based compensation or incentive scheme in respect of the Group; or

iv. take any action that would not be permitted (or would only be permitted after an affirmative shareholder vote) if the Company were admitted to the Premium Segment of the Official List.

The holder of the Sponsor Share has the right to require that: (i) any purchase or redemption by the Company of its shares; or (ii) the Company's ability to amend the memorandum and articles of association of the Company, be subject to a special resolution of members whilst the Sponsor (or an individual holder of a Sponsor Share) holds directly or indirectly 5 per cent. or more of the issued and outstanding shares of the Company (of whatever class other than any Sponsor Shares) or are a holder of Incentive Shares.

13.  RESERVES

The following describes the nature and purpose of each reserve within shareholders' equity:

Accumulated losses

Cumulative losses recognised in the Consolidated Statement of Comprehensive Income.

Share based payment reserve

The share based payment reserve is the cumulative amount recognised in relation to the equity-settled share based payment scheme as further described in Note 15.

Warrant reserve

The Warrant reserve is the cumulative fair value attributed to warrants issued attached to Ordinary Shares.

A Warrant reserve

The A Warrant reserve is the cumulative fair value attributed to warrants issued attached to A Shares.

14. FINANCIAL INSTRUMENTS AND ASSOCIATED RISKS

The Group has the following categories of financial instruments:

As at

31 December 2025

 

As at

30 June

2025

Unaudited

 

Audited

£'s

 

£'s

Financial assets measured at amortised cost

Cash and cash equivalents (Note 10)

265,120

464,322

265,120

 

464,322

Financial liabilities measured at amortised cost

Trade and other payables (Note 11)

38,399

54,035

Due to a related party (Note 16)

21,540

33,847

Incentive Share liability (Note 15)

29,338

-

89,277

 

87,882

The fair value and book value of the financial assets and liabilities are materially equivalent.

The Group's risk management policies are established to identify and analyse the risks faced by the Group, to set appropriate risk limits and controls, and to monitor risks and adherence limits. Risk management policies and systems are reviewed regularly to reflect changes in market conditions and the Group's activities.

Treasury activities are managed on a Group basis under policies and procedures approved and monitored by the Board. These are focussed on maximising the interest earned by the Group on its cash deposits (refer Note 10). through effective management of the amount available to be placed on deposit being cognisant of the ongoing working capital requirements of the Company. Any movement in interest rates will not have a significant effect on the Company or its ability to continue to pursue its stated strategy and such movements are therefore not considered to be a material risk to the Company.

As the Group's assets are predominantly cash and cash equivalents, market risk and liquidity risk are not currently considered to be material risks to the Group.

15. SHARE-BASED PAYMENTS

Management Long Term Incentive Arrangements

The Group has put in place a Long-Term Incentive Plan ("LTIP"), to ensure alignment between shareholders, and those responsible for delivering the Company's strategy and attract and retain the best executive management talent.

The LTIP will only reward the participants if shareholder value is created. This ensures alignment of the interests of management directly with those of shareholders. Under the LTIP Incentive Shares are issued by the Subsidiary. On inception of the LTIP, 2,000 Incentive Shares were issued by the Subsidiary to MLTI and on 3 October 2025 1,600 Incentive Shares were issued by the Subsidiary to Avril Palmer-Baunack.

At the balance sheet date, Avril Palmer-Baunack and MLTI were the only participants in the LTIP, but it is the expectation that participants in the LTIP may ultimately include any further members of the Company's management team as well as senior executives of the acquired businesses or companies as part of their respective executive compensation schemes.

Preferred Return

The incentive arrangements are subject to the Company's shareholders achieving a preferred return of at least 7.5 per cent. per annum on a compounded basis on the capital they have invested time to time (with dividends and returns of capital being treated as a reduction in the amount invested at the relevant time) (the "Preferred Return").

Incentive Value

Subject to a number of provisions detailed below, if the Preferred Return and at least one of the vesting conditions have been met, the holders of the Incentive Shares can give notice to redeem their Incentive Shares for Ordinary Shares in the Company for an aggregate value equivalent to 20 per cent. of the "Growth", where Growth means the excess of the total equity value of the Company and other shareholder returns over and above its aggregate paid up share capital (20 per cent. of the Growth being the "Incentive Value").

Grant Date

The Grant Date of the Incentive Shares will be the date that such shares are issued.

Service Conditions and Leaver Provisions

There are leaver provisions in relation to the Incentive Shares issued to Avril Palmer-Baunack which are set out in her subscription agreement dated 3 October 2025.

If Avril Palmer-Baunack leaves in circumstances in which she is deemed to be a "Good Leaver" (being any reason other than a bad leaver circumstance), then she will be entitled to retain the vested portion of the Incentive Shares. Any unvested Incentive Shares will either be compulsorily redeemed or acquired at the lower of the (i) the subscription price or (ii) the market value for such Incentive Shares. Accordingly, at the balance sheet date, £29,338 is recognised as a liability within trade and other payables (refer Note 11) (30 June 2024: £Nil), being the subscription price of the shares.

If Avril Palmer-Baunack is deemed to be a "Bad Leaver" (such as termination of employment for gross misconduct, fraud or criminal acts) then she will be required to sell her Incentive Shares back to the Subsidiary for a total consideration of £0.01.

Redemption / Exercise

Unless otherwise determined and subject to the redemption conditions having been met, the Company and the holders of the Incentive Shares have the right to exchange each Incentive Share for Ordinary Shares in the Company, which will be dilutive to the interests of the holders of Ordinary Shares. However, if the Company has sufficient cash resources and the Company so determines, the Incentive Shares may instead be redeemed for cash. It is currently expected that in the ordinary course of business, Incentive Shares will be exchanged for Ordinary Shares. However, the Company retains the right but not the obligation to redeem the Incentive Shares for cash instead. Circumstances where the Company may exercise this right include, but are not limited to, where the Company is not authorised to issue additional Ordinary Shares or on the winding-up or takeover of the Company.

Any holder of Incentive Shares who exercises their Incentive Shares prior to other holders is entitled to their proportion of the Incentive Value to the date that they exercise but no more. Their proportion is determined by the number of Incentive Shares they hold relative to the total number of issued shares of the same class.

Vesting Conditions and Vesting Period

The Incentive Shares are subject to certain vesting conditions, at least one of which must be (and continue to be) satisfied in order for a holder of Incentive Shares to exercise its redemption right.

The vesting conditions are as follows:

i. it is later than the third anniversary of an Initial Acquisition and earlier than the seventh anniversary of an Initial Acquisition;

ii. a sale of all or substantially all of the revenue or net assets of the business of the Subsidiary in combination with the distribution of the net proceeds of that sale to the Company and then to its shareholders;

iii. a sale of all of the issued Ordinary Shares of the Subsidiary or a merger of the Subsidiary in combination with the distribution of the net proceeds of that sale or merger to the Company's shareholders;

iv. whereby corporate action or otherwise, the Company effects an in-specie distribution of all or substantially all of the assets of the Group to the Company's shareholders;

v. aggregate cash dividends and cash capital returns to the Company's shareholders are greater than or equal to aggregate subscription proceeds received by the Company;

vi. a winding-up of the Company;

vii. a winding-up of the Subsidiary; or

viii. a sale, merger or change of control of the Company.

If any of the vesting conditions described in paragraphs (ii) to (viii) above are satisfied before the third anniversary of an Initial Acquisition, the Incentive Shares will be treated as having vested in full.

Holding of Incentive Shares

MLTI and Avril Palmer-Baunack hold Incentive Shares entitling them in aggregate to 100 per cent. of the Incentive Value. Any future management partners or senior executive management team members receiving Incentive Shares will be dilutive to the interests of existing holders of Incentive Shares, however the share of the Growth of the Incentive Shares in aggregate will not increase.

The following shares were in issue as at 31 December 2025:

Issue date

Name

Nominal Price

Issue price per Incentive Share

£'s

Number of Incentive Shares

Unrestricted market value at Grant Date £'s

IFRS 2 Fair value £'s

25 November 2021

MLTI

£0.01

7.50

2,000

15,000

67,516

3 October 2025

Avril Palmer-Baunack

£0.01

18.34

1,600

29,338

116,034

Valuation of Incentive Shares

Valuations were performed by Deloitte LLP using a Monte Carlo model to ascertain the unrestricted market value and the fair value at Grant Date. Details of the valuation methodology and estimates and judgements used in determining the fair value are noted herewith and were in accordance with IFRS 2 at Grant Date.

There are significant estimates and assumptions used in the valuation of the Incentive Shares. Management has considered at the Grant Date, the probability of a successful Initial Acquisition by the Company and the potential range of value for the Incentive Shares, based on the circumstances on the Grant Date.

The fair value of the Incentive Shares granted under the scheme was calculated using a Monte Carlo model with the following inputs:  

Issue date

Name

Share designation at balance sheet date

Volatility

Risk-free rate

Expected term* (years)

25 November 2021

MLTI

Redeemable A ordinary shares

25%

0.7%

7.0

3 October 2025

Avril Palmer-Baunack

Redeemable A ordinary shares

25%

4.1%

7.0

\* The expected term assumes that the Incentive Shares are exercised 7 years post acquisition.

The Incentive Shares are subject to the Preferred Return being achieved, which is a market performance condition, and as such has been taken into consideration in determining their fair value. The model incorporates a range of probabilities for the likelihood of an Initial Acquisition being made of a given size.

Expense related to Incentive Shares

As there is a service condition associated with the shares issued to Avril Palmer-Baunack, in accordance with IFRS 2, the fair value of her Incentive Shares, less the subscription price, is expensed over the expected vesting period. Accordingly, an expense of £4,335 (31 December 2024: £Nil) has been recognised in the Consolidated Statement of Comprehensive Income with a corresponding increase in the share-based payment reserve.

There are no service conditions attached to the MLTI shares and as result the fair value at Grant Date was expensed to the profit and loss account on issue with a corresponding increase in the share-based payment reserve.

16. RELATED PARTIES

James Corsellis, Antoinette Vanderpuije and Tom Basset have served as Directors of the Company during the period. James Corsellis is Chief Investment Officer of MIM LLP, and Antoinette Vanderpuije and Tom Basset are partners of MIM LLP. MIM LLP is the manager of the Marwyn Fund, the Marwyn Fund holds 90 per cent. of the Company's issued Ordinary Shares, 100% of the A Shares and 1 Sponsor Share.

MVI II LP is an entity within the Marwyn Fund, the Company has entered into an FPA with MVI II LP under which the Company drew down £Nil during the period ending 31 December 2025 (30 June 2025: £500,000). The funds received from drawdowns were passed from the Company to the Subsidiary, by way of a capital contribution, without the receipt of any additional shares or debt.

James Corsellis is the managing partner of Marwyn Capital LLP ("MC LLP"), and Antoinette Vanderpuije and Tom Basset are also partners. MC LLP provides corporate finance and managed services support including named company secretary to the Company. On an ongoing basis a monthly fee of £10,994 per calendar month (£10,470 up to February 2025) is charged for the provision of the corporate finance services, and managed services support is charged by MC LLP on a time spent basis. The total amount charged in the period ended 31 December 2025 by MC LLP was £97,514 (31 December 2024: £82,795) and the total expenses incurred on behalf of the Group, which were subsequently recharged, were £5,460 (31 December 2024: £8,365). An amount payable to MC LLP of £21,540 (30 June 2025: £33,847) was outstanding as at the balance sheet date.

17. COMMITMENTS AND CONTINGENT LIABILITIES

There were no commitments or contingent liabilities outstanding at 31 December 2025 (30 June 2025: £Nil) which would require disclosure or adjustment in these Interim Financial Statements.

18. POST BALANCE SHEET EVENTS

There have been no material post balance sheet events that would require disclosure or adjustment to these Interim Financial Statements.

ADVISERS

Company Secretary

BVI legal advisers to the Company

Antoinette Vanderpuije

Conyers Dill & Pearman

11 Buckingham Street

Commerce House

London

Wickhams Cay 1

WC2N 6DF

Road Town

Email: [email protected]

Tortola

British Virgin Islands

VG1110

Registered Agent

Depository

Conyers Trust Company (BVI) Limited

MUFG Corporate Markets Trustees (UK) Limited

Commerce House

Central Square

Wickhams Cay 1

29 Wellington Street

Road Town

Beckenham

Tortola

Leeds

British Virgin Islands

LS1 4DL

VG1110

English legal advisers to the Company

Registrar

Travers Smith LLP

MUFG Corporate Markets (Guernsey) Limited

10 Snow Hill

Mont Crevelt House

London

Bulwer Avenue

EC1A 2AL

St Sampson

Guernsey

GY2 4LH

Registered office

Independent auditor

Commerce House

Baker Tilly Channel Islands Limited

Wickhams Cay

2nd Floor Lime Grove House

1 Road Town

Green Street

Tortola

St Helier

British Virgin Islands

Jersey

VG1110

JE2 4UB

Assistant Company Secretary

Conyers Corporate Services (BVI) Limited

Commerce House

Wickhams Cay 1

Road Town

Tortola

British Virgin Islands

VG1110

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR XDLFFQXLZBBX

Related Shares:

Mac Alpha
FTSE 100 Latest
Value10,107.72
Change44.22